The proepicardium is a transient structure comprising epicardial progenitor cells located at the posterior limit of the embryonic cardiac inflow. A network of signals regulates proepicardial cell fate and defines myocardial and nonmyocardial domains at the venous pole of the heart. During cardiac development, epicardial-derived cells also contribute to coronary vessel morphogenesis.
T he early vertebrate heart consists of 2 tissue layers, the outer myocardium and the inner endocardium. At embryonic day (E)9.5 in mice, a third tissue, the epicardium, migrates to envelop the outer surface of the myocardium, actively participating in coronary vessels (CVs) morphogenesis and compact ventricular myocardium growth. 1 Epicardial progenitors are found in the proepicardium, a grape-like structure with characteristic protrusions (proepicardial villi). The proepicardium arises by E9.0 through local proliferation of the coelomic epithelium covering the septum transversum at the posterior limit (venous pole) of the heart. 2 The mesodermal progenitors underneath the proepicardium are often referred to as "posterior pericardial mesoderm," 3 a term that refers to topology rather than an embryological relation to the pericardial membranes. The venous pole of the heart provides the developing heart with myocardium, 4 a process that in the mouse finishes with the muscularization of the sinus horns. 5 The completion of the primitive epicardial epithelium covering the myocardium is followed by the appearance of the subepicardium, 1 an abundant extracellular matrix separating epicardium and myocardium. Concomitantly, the epicardium undergoes an epithelial-tomesenchymal transition (EMT) and populates the subepicardium with mesenchymal epicardial-derived cells (EPDCs) , that contribute to the development of CVs and cardiac interstitium. 1 Proepicardial cells (proEPCs) can differentiate in vivo and in vitro into vascular/fibroblastic cell types or myocardium depending on the conditions. 3 A recent study proposed that proepicardial fate depends on the balance between Bmps and Fgfs signals, Bmps promoting myocardial differentiation and Fgfs favoring vascular/fibroblastic differentiation or simply sustaining the primitive epithelial phenotype of proEPCs. 6 The epicardium is a pivotal tissue for cardiac development, because epicardial-derived signals must coordinate CV development and myocardial growth. The proepicardial-epicardial-EPDC transition is tightly regulated in space and time. First, the transfer of proEPCs to the heart surface is coordinated with the establishment of the posterior limit for cardiac inflow myocardium, a process requiring fine control of posterior pericardial mesoderm differentiation. 5 Secondly, coronary development requires interaction between the various cell types that build or support the growth of the CV tree 7 and myocardial growth. 8 A candidate molecular system to integrate these signals is the Notch pathway, a local cell signaling mechanism in which ligands (Delta1, -3, and -4 and Jagged1 and -2) and receptors (Notch1 to -4) are membranebound. Ligand-receptor binding initiates 2 consecutive receptor cleavage steps, the last one involving ␥-secretase, that generates the biologically active Notch intracellular domain (NICD). 9 In the nucleus, NICD binds the RBPJK/CSL transcription factor, regulating cell fate specification, differentiation and patterning. 10 Notch is essential for cardiac valve formation, 11, 12 ventricular trabeculation 13 and outflow tract development. 14 Notch is also expressed during chick coronary vascular development 15 and it is integrated with provascular signals such as VEGF. 16 We describe the differential expression of Notch signaling components and the effect of defective Notch signaling, during proepicardial, epicardial and CV development in the mouse. At E9.5, proepicardial Notch2 signaling correlates with low Bmp2 activity, whereas Bmp2 activity is abnormally high in mice lacking the Notch effector RBPJK. This is associated with precocious muscularization of SV horns, and blockade of Notch signaling in vitro initiates cardiomyocyte differentiation in proEPCs. The embryonic and neonatal segregation of Notch1 to putative arterial endothelium and Notch2 to epicardial epithelium and nondifferentiated perivascular EPDCs, suggests that vessel growth and maturation are coordinated through active interplay between the 2 Notch receptors. Consistently, epicardial-specific ablation of Notch1 receptor using a Wt1-Cre driver line (Wt1;N1) causes severe dysmorphogenesis of coronary arteries and myocardial hypoplasia. Myocardial hypoplasia was also detected in Notch1 gain-of-function experiments in Wt1;N1ICD mice. Our results demonstrate the essential role of Notch in proepicardium, epicardium and CV development and highlight the therapeutic potential of targeting Notch.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animal experiments were performed according to Institutional and European Union guidelines. RBPJk, 17 Notch1 flox 18 , R26N1ICD 19 and Rosa26R 20 mice [B6.129S4-Gt(ROSA)26Sortm1Sor/J] were genotyped by PCR analysis of yolk sacs or tail DNA.
A BAC recombineering strategy was used to insert an IRES/ EGFP-CRE cassette into the 3Ј UTR of a full-length mouse Wilms tumor-1 (Wt1) gene. The resulting BAC clone was used to generate independent transgenic mouse lines expressing Cre in the epicardial lineage from the proepicardial stage. A detailed description of these Wt1-Cre transgenic mice will be provided elsewhere.
Results

Notch Signaling Activity During Proepicardial Development Is Attenuated in RBPJk Mutants
At E9.5, the wild-type (WT) proepicardium is fully formed. Delta1, Delta4 and Jagged1 expression was restricted to Figure 1G ) were detected in proepicardium and PM, active Notch2 (N2ICD) was confined to proepicardium ( Figure 1F ), similar to the ligands. Semiquantitative (sq)RT-PCR of E9.5 WT proepicardia confirmed these observations and revealed weak Jagged2 expression ( Figure 1B) .
Proepicardium of RBPJk mice showed normal morphology ( Figure 1I Figure 1K, 1N , and 1O) and Hes1 mRNA and protein ( Figure 1K , 1P, and 1Q) was markedly decreased. Expression of Snail1, which mediates Notch-triggered EMT during cardiac valve development, 11 was also lower in RBPJk embryos ( Figure 1K , 1R, and 1S). These data indicate that Notch pathway elements are expressed in WT E9.5 proepicardium but that defective Notch signaling in RBPJk embryos does not affect proepicardium formation.
Ectopic Bmp2 Expression and Signaling in RBPJk Proepicardium
Cell fate decisions in the proepicardium are regulated by Bmp-Fgf crosstalk. 3 In WT embryos, Bmp2 was restricted to the posterior myocardial limit of the SV and a narrow band of PM ( 
Precocious Cardiac Inflow Muscularization in RBPJk Embryos
Expression of transcriptional regulators of myocardial differentiation (Gata4, Nkx2.5, Islet1), in the cardiac inflow (CI) was unaltered in RBPJk embryos (Online Figure II , E, F, and M through P). In contrast, the sarcomeric protein Tpm1 and the early cardiac marker ␣-SMA were prematurely expressed in mutant SV horns and DAPI (blue) counterstain myocardium and cell nuclei, respectively. F, WT: Tpm1 expression is restricted to myocardium (thick arrow) and is absent from PE (arrow) and PM (arrowhead). G and H, RBPKO: Ectopic Tpm1 expression at the base of the PE (arrow) (G) and in the SH (thick arrow, H). Note the shortened and thickened SV wall (thick arrow, G). I, WT: ␣-SMA expression in the SV myocardium (thick arrow) but not in PE (arrow). J and K, RBPKO: ␣-SMA expression extends to the base of PE (J, arrows) and cell clusters at the posterior limit of SV myocardium (thick arrow and inset, K). SH indicates sinus horns; SV, sinus venosus. L and M, Threedimensional reconstruction of the PE region in WT (L, detail in LЈ) and RBPKO embryos (M, detail in MЈ). Body (blue), heart (red), pericardial mesoderm and proepicardium (PMP) (transparent green), and ␣-SMA expression in PMP (purple). L, ␣-SMA was not detected in the PMP region of WT embryos, whereas ectopic expression was detected in RBPKOs (arrows, LЈ and MЈ). 
Notch Signals Are Differentially Expressed During Epicardial, EPDC, and CV Development
By E11.5, epicardial spreading has ended. The patterns of Delta4 and Delta1 expression were similar in both the epicardium and EPDC ( Figure 4A and data not shown), whereas weaker Jagged1 and Jagged2 expression was found in EPDC ( Figure 4B and data not shown). Like Delta1/4, Notch2 (Online Figure I , C and D), Notch3 and Notch4 (data not shown) were found in the epicardium and EPDCs. Notch1 was restricted to EPDCs (Online Figure I , G), and N1ICD was present only in an EPDC subpopulation, most likely developing CVs ( Figure 4C ). This pattern was maintained at E12.5, with N1ICD restricted to endothelial EPDCs contacting or intruding the compact myocardium, and costaining with the endothelial marker isolectin (I)-B4 (Online Figure I , I and J). In contrast, N2ICD was mainly expressed in epicardium and a few EPDC ( Figure 4D ). Expression of Snail1 in EPDCs ( Figure 4E ) matched that of N1ICD. Hey1-3/L expression was evident in epicardium and EPDC ( Figure 4F and 4G and not shown) and patchy Hes1 protein expression was seen in groups of epicardial cells and EPDCs ( Figure 4H ). At E14.5, after the coronary tree is established, Delta4 and Jagged2 were expressed in the coronary artery endothelium, but not in epicardium or EPDCs ( Figure 4I and 4IЈ and not shown). Delta1 was maintained in epicardium, EPDCs, CV endothelium and surrounding smooth muscle cells (SMCs) (not shown). Jagged1 was expressed in the epicardium, EPDCs and CV endothelium and SMC ( Figure  4J and 4JЈ). N1ICD was expressed in coronary artery endothelium, similar to the pattern of Notch4 ( Figure 4K and not shown), whereas Notch2 and Notch3 expression patterns were maintained in epicardial cells and EPDCs, including coronary SMCs ( Figure 4L and LЈ and not shown). Hey1-3/L and Hes1 were all expressed in the coronary artery endothelium ( Figure 4M through 4P) , and Hey2 and Hes1 were also expressed in epicardium and EPDCs ( Figure 4N and 4P).
Notch pathway expression was maintained in neonatal and adult CVs (Online Figure IV) . Delta1 and Delta4 were expressed in neonate and adult SMC (Online Figure IV Table I summarizes Notch signaling element expression in the CIR and the epicardial lineage, illustrating the clear spatio-temporal segregation of Notch signals in the proepicardium (Notch2/N2ICD), epicardium (Notch2), subepicardial mesenchyme (Notch1), and prospective CVs (Notch1/ N1ICD) as development proceeds. It is noteworthy that early Notch1 and Notch2 expressions are mutually exclusive, with Notch1/4 being progressively confined to the arterial endothelium and Notch2/3 mainly distributed in perivascular and mural cells.
Epicardial-Specific Notch1 Ablation Results in CV and Compact Myocardium Defects
The earliest evidence of Notch1 epicardial activity was found at E11.5 ( Figure 4C ). To examine Notch1 function in epicardium and CV development we used a conditional Notch1 allele 18 that we crossed with our epicardial driver line mWt1/IRES/GFP-Cre (Wt1Cre). Tissue specificity of this Wt1Cre line was confirmed by crossing with the lineage reporter Rosa26R. 20 At E8.5, Wt1 promoter activity was detected in 2 lateral strips of proepicardial precursors on either side of the septum transversum (Online Figure V, D) . At E9. Figure V, N) , where cells originating from the epicardium have been described. 26 The Wt1Cre line thus recapitulates the expected gene expression pattern of Wt1 in epicardium and EPDCs.
The Wt1Cre line was crossed with Notch1 flox mice, generating Wt1Cre /ϩ ;Notch1 flox/flox mice (Wt1;N1). At E13.5, most Wt1;N1 embryos display body and pericardial hemorrhages ( Figure 5A and 5B) and die shortly afterward. Efficient epicardial deletion of Notch1 was confirmed by lack of staining with N1ICD antibody in EPDCs (compare Figure 5E and 5G with Figure 5F and 5H), whereas endocardial N1ICD expression was maintained ( 27 ; Figure 5E and 5G versus Figure 5F and 5H). CD31 immunostaining in E13.5 wholemount hearts revealed severe reduction and disorganization of the coronary vascular plexus ( Figure 5I and 5J) , as confirmed by OPT (Online Movies I and II). CVs were scarce in the compact ventricular myocardium of Wt1;N1 mutants ( Figure 5K and 5L) , particularly the deep myocardium, whereas subepicardial vessels of venous aspect occupied a larger area ( Figure 5K , 5L, 5S, and 5T; see below). Analysis of the smooth muscle marker SM22 revealed a reduction in the number of SMCs in the compact myocardium (Figure 5M Wt1;N1 mutants (F, arrowhead) . WT (G) and Wt1;N1 mutant (H) hearts at E13.5. Intramyocardial coronary endothelial cells (dashed line) express N1ICD in WT (G, arrow) but not in Wt1;N1 mutants (H, arrow). N1ICD endocardial expression is maintained (G and H, arrowheads) . I and J, CD31 whole mount staining (E13.5). Wt1;N1 (J) hearts display a poorly organized coronary vascular plexus as compared to WT ones (I). K and L, CD31 staining on sections indicates that coronary arteries are absent from the compact myocardium of Wt1;N1 mutants (L, arrow; compare to WT, K). Coronary veins normally appear in the subepicardium (K and L, thick arrowheads). Myocardium is ␣-SMA ϩ (red) and endocardium (green) is indicated by arrowheads. M and N, SM22 staining (red) shows reduced SMC in Wt1;N1 mutants (N, arrow) as compared to WT (M, arrows). O and P, ISH: EphrinB2 is expressed in the coronary arteries of E13.5 WT embryos (O, arrow) but not in Wt1;N1 embryos (P, arrow). Q and R, CD31/␣-SMA stainings of E13.5 hearts indicate the presence of communications between the endocardium (Q, arrowhead) and epicardium (Q, thick arrow). Arterioventricular connections with an inner endothelial lining (R, arrow) and an outer SMC wall (R, arrowhead) can also occur. S and T, Analysis of coronary veins: the number of veins/section is reduced in the mutant (S), but the average area occupied by these vessels is larger in Wt1;N1 mutants (T). Results are expressed as meansϮSD. *PϽ0.05. ca indicates coronary arteries; cv, coronary veins; endo, endothelium; endoc, endocardium; epi, epicardium; SMC, smooth muscle cells.
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WT (E) and Wt1;N1 mutants (F). N1ICD is expressed by WT EPDC (E, thick arrow) but not Wt1;N1 EPDC (F, thick arrow). Endocardial N1ICD staining (E, arrowhead) remains unaffected in
versus Figure 5N ). EphrinB2 expression was found in CVs buried in the ventricular myocardium of WT but not mutant embryos ( Figure 5O and 5P) , confirming that the affected vessels were arterial. This abnormal coronary development was associated with endocardial-subepicardial connections that in severe cases resulted in cysts composed of an endothelial lining (CD31 ϩ ; Figure 5R ) connected to the outer ventricular myocardium ( Figure 5Q ). Wt1;N1 mice had reduced vein density ( Figure 5S ).
The coronary phenotype of Wt1;N1 mice was associated with a severe reduction in compact myocardium thickness ( Figure 6A through 6D) . The number of compact myocardium nuclei was significantly lower (25% to 30%; nϭ5; Figure 6E ). At E13.5, Wt1;N1 mutants showed a sharp reduction in 5-bromodeoxyuridine (BrdUrd)-positive cells (more than 30% reduction; nϭ5; Figure 6F through 6H), indicating that the reduced compact myocardium thickness was attributable to diminished proliferation. Epicardially derived RA indirectly promotes cell proliferation in compact myocardium, 8 and we found that Raldh2 was markedly reduced in the epicardium of E13.5 Wt1;N1 mutants ( Figure 6I and 6J) . Cre activity labeled the epicardium at this stage (Online Figure V, J) , indicating Wt1Cre-mediated Notch1 deletion as the likely caused of reduced Raldh2 expression and diminished compact myocardium proliferation in Wt1;N1 mutants.
Epicardial-Specific N1ICD Ectopic Expression Impairs Formation of Epicardium and Compact Myocardium
To examine the effect of Notch gain of function in the epicardium we crossed the Wt1Cre driver line with R26N1ICD mice, 19 generating Wt1Cre /ϩ ;R26N1ICD /ϩ mice (Wt1;N1ICD). Wt1;N1ICD died at E15.5, with pericardial bleeding suggesting severe cardiac failure as the cause (not shown). At E14.5, H&E staining detected reduced subepicardium thickness ( Figure 7A and 7B) . Quantification of cell nuclei revealed no change in cell number ( Figure 7L ), suggesting that reduced thickness was attributable to extracellular matrix defects. Compact myocardium thickness was also reduced in Wt1;N1ICD embryos ( Figure 7C and 7D); nuclei quantification showed that ventricular wall thickness was reduced by 25% to 30% (Figure 7P ), similar to Wt1;N1 mice ( Figure 6E ). The epicardial markers cytokeratin 1 (CK1) and Raldh2 showed a discontinuous expression pattern in Wt1;N1ICD embryos ( Figure 7E through 7H), confirming defective epicardial integrity. Gaps in epicardium were usually associated with cysts ( Figure 7I through 7K ), similarly to Wt1;N1 embryos ( Figure 5R ), and epicardial blistering ( Figure 7M through 7O). CD31 and CK1 stainings ( Figure 7J, 7K, 7N , and 7O) showed that in Wt1;N1ICD embryos these structures were formed, at least partially, by epicardial cells (Figure 7K and 7O).
Discussion Notch Pathway Components Are Widely Expressed During Epicardium Development
The molecular networks that govern epicardial development, including the formation of the proepicardium and epicardium, the emergence and differentiation of EPDCs, and their contribution to CV development, have only recently come 
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into view. 28 Our study provides data on the expression and function of Notch elements throughout the development of the epicardial lineage. Our results demonstrate that Notch ligands (Delta1, Delta4 and Jagged1) and receptors (Notch2-4, but not Notch1) are present and/or active in the developing epicardial progenitor (proepicardium). Ligands are restricted to proepicardium, whereas expression of Notch receptors is more widespread, encompassing the PM caudal to the developing cardiac inflow and dorsal to the proepicardium. Notch2 activity is restricted to proepicardium, and expression of the Notch targets Hey2, Hes1, and Snail1 is altered in RBPJk mutants, suggesting that Notch is normally active in the proepicardium. Differential activation of Notch signaling in the proepicardium and surrounding PM of the septum transversum may have a role not only in determining proepicardial fate, but also in regulating CI development.
Notch Signaling Inactivation Alters CI Differentiation by Inducing Ectopic Proepicardial Bmp2 Expression
The signals that control outgrowth of the coelomic mesoderm to form the proepicardium are under intense investigation. 29 Genes required for proepicardium development were generally unaffected in RBPJk mutants, suggesting that Notch is not critical for proepicardium formation or growth. The Fgf and Bmp signaling pathways are pivotal for the acquisition of proepicardial cell fates. 3 Bmp4, Bmp2 and Fgf8 expression all promote myocardial differentiation at the CI, and Bmps are known to drive proepicardial differentiation into myocardium in vitro. 3 Complete Notch signaling abrogation in RBPJk mutants expanded Bmp2 from the PM adjacent to the SV toward the proepicardium, but did not affect expression of Fgfs. This ectopic Bmp2 expression did not correlate with changes in proepicardial morphology, ;N1ICD embryos (F, arrow) . G and H, Expression of Raldh2 mRNA also decreases in Wt1;N1ICD epicardium (G and H, arrows). Anomalous local epicardial thickenings (cysts) are frequent (I through K, arrowheads). L, Cell number in the subepicardium is unaffected. M through O, Blistering was also detected (arrowheads). P, Cell number in compact myocardium is reduced in Wt1;N1ICD heart. In all cases, myocardium is ␣-SMA ϩ (red). Data are meansϮSD. *PϽ0.05.
suggesting that Bmp2 is not required for mammalian proepicardial formation, contrasting with its pivotal role during avian proepicardial development. 30 Increased Bmpdependent signaling in RBPJk mutants was deduced on the basis of higher nuclear p-Smad 1/5/8 expression in the proepicardium and associated PM, and indicated that Bmp2 activity was expanded to the entire inflow region. Ectopic muscular differentiation at the venous pole of the heart in RBPJk mutants, revealed by the expression of cardiomyogenic markers such as Tpm1, ␣-SMA, cardiac troponin T, and cardiac actin suggests that muscularization of the SV horns had occurred prematurely. This is consistent with the role of Notch as an inhibitor of cardiomyogenesis during heart formation in Xenopus 31 and mesodermal differentiation of ES cells. 32 This idea is also supported by the increased expression of sarcomeric myosin (MF20 ϩ ) and early myocyte marker ␣-SMA in proepicardial explants cultured with the Notch pathway inhibitor DAPT, directly relating CI anomalies to increased differentiation of cardiac muscle from proepicardium. Addition of BMP2 to proepicardial cultures has the same effect, suggesting that the myogenesis caused by Notch signaling abrogation is mediated by Bmp2. However, the possible contribution of other nonproepicardial sources of heart progenitors to the CI phenotype of RPBJk mutants, cannot be ruled out.
The early proepicardial expression and activity of Notch2 make it a candidate regulator of developmental cell fate decisions at the CI. Moreover, proepicardial Notch signaling might define the posterior myocardial limit of the developing heart, because altered proepicardial Notch signaling affected the muscularization of the cardiac inflow. This might be explained by the downregulation of Hes1 and, more importantly, Hey2, an inhibitor of Bmp2 gene expression during AVC development. 33 Notch signaling thus may inhibit Bmp2 expression in the proepicardium thereby repressing its differentiation into muscle and establishing a posterior border for myocardial differentiation in the SV.
Role of Notch Receptors in Epicardial and EPDC Differentiation and CV Growth and Maturation
At E11.5, Notch2-4 expression was found in the epicardium and EPDC, with N2ICD detected only in the epicardium and very few EPDCs. Notch1 expression, however, was restricted to subepicardial EPDC, with N1ICD staining detected only in a portion of Notch1 ϩ EPDCs, giving rise to the early outline of CV. Notch signaling through Delta and Jagged ligands, as well as the activation of Notch targets Hey1-3/L, were also evident in the epicardium of E14.5 mice. These findings differ somewhat from previous publications on epicardial development in mouse 34 and chick, 15 in which N1ICD was reported in proepicardium and early epicardium at HH21. These seemingly contradictory results may reflect differences between avians and mammals.
Activation of Notch2 in proepicardium and epicardium suggests a dual function of this receptor, simultaneously inhibiting myocardial differentiation and sustaining primitive epicardial features (primitive lateral plate mesoderm epithelium). In parallel, Notch1, essential for maintaining the undifferentiated cell state during embryonic development, 10 may also support an undifferentiated state in the epicardium, a multipotent tissue. 1 Notch1 regulates prevalvular endocardial EMT by activating Snail1, 11 and may also promote epicardial EMT to yield EPDCs. EPDCs contribute to CV development by differentiating into SMC, fibroblasts, and endothelial cells. 35 The complementarity of Notch expression and activity during CV development indicates that Notch promotes coronary artery development by first committing arterial endothelial precursors, and then driving SMC recruitment and/or differentiation during coronary arteriogenesis. This process requires a dynamic change of Notch expression, with some elements maintaining their epicardial and EPDC expression, and others restricting their distribution to the vascular endothelium. The phenomenon is apparently independent of coronary vein formation, although we did observe minor alterations in the formation of these vessels. Our data suggest that Notch receptors promote essential processes in CV development, namely arterial endothelium differentiation (Notch1) and differentiation of perivascular cells (Notch2 and Notch3). Such a topological segregation is consistent with delayed differentiation of smooth muscle with respect to the endothelium 36 and the high expression of ␣-SMA found in nonmyocyte cells (MF20-) in DAPTtreated proepicardial cultures. It remains to be investigated whether these different expression patterns reflect the genetic programs of independently committed cell lineages, or the activation of Notch signaling in response to external cues such as VEGF. 16 
The Precise Balance of Notch1 Signaling Determines CV Morphogenesis and Compact Myocardium Development
Notch1 epicardial-specific deletion produced major CV defects and myocardial hypoplasia by E13.5, leading to embryonic lethality in severe cases. The most important phenotype of Wt1;N1 mutants was reduced coronary vasculature, mainly affecting the EphrinB2 ϩ putative coronary arteries embedded in the compact myocardium, whereas the subepicardial venous vascular bed presented only minor defects. The mechanism by which coronary branches relocate from the subepicardium to the deeper ventricular myocardial layers is unclear, although intramyocardial vasculogenesis has been proposed. 37 The defects in Wt1;N1 mutants implicate Notch1 not only in coronary arterial fate specification and muscularization, but also in the migration of blood vessel progenitors from the subepicardial space into the compact myocardium. Interestingly, Wt1;N1ICD mice do not show apparent defects in the coronary arteries (data not shown) suggesting that coronary endothelium is less sensitive to the excess of Notch activity.
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Another relevant defect of Wt1;N1 mice was compact myocardium hypoplasia. BrdUrd incorporation studies demonstrated that myocardial hypoplasia in Wt1;N1 mutants might be caused by decreased proliferation. RA signals can trigger, in an autocrine fashion, epicardial secretion of molecules inducing proliferation of neighboring compact myocardium. 8 The nature of these mitogenic molecules is unknown, although Fgfs have been suggested. 38 Reduced Raldh2 expression in the epicardium of Wt1;N1 (and Wt1;N1ICD) embryos, might explain the low proliferation in the compact myocardium. Because Notch1 expression is restricted mainly to EPDCs, we presume that Notchdependent signals in EPDCs are required to sustain epicardial Raldh2 expression. Alternatively, deficient vascularization of the myocardium might affect signals promoting epicardial Raldh2 transcription. In any case, myocardial hypoplasia is associated with the appearance of arterioventricular connections (fistulae). Wt1;N1ICD mice also show myocardial hypoplasia but unlike Wt1;N1 mutants, epicardial morphology is defective and Tbx18 and CK1 expression is abrogated. This indicates a primary structural and differentiation defect in epicardium caused by ectopic N1ICD activity that may secondarily impair Raldh2 expression.
The analysis of Notch1 loss-and gain-of-function in epicardium confirms that this pathway regulates arterial endothelium differentiation and suggests a critical function in precursor cell migration throughout the compact myocardium to form the coronary arteries. Additionally, epicardial Notch signaling may be indirectly involved in the growth of compact ventricular myocardium through the modulation of proliferative signals (Raldh2). Notch-dependent functions during proepicardial-epicardial-CV development are summarized in Figure 8 .
Our study identifies multiple roles for Notch receptors in the regulation of epicardial biology. These include proepicardial-epicardial differentiation and CV morphogenesis and secondary roles in CI muscularization and ventricular myocardial growth. Detailed knowledge of these aspects of cardiac development is crucial to understanding the molecular and cellular basis of several congenital diseases and for the development of methods to revascularize the damaged myocardium. 
Novelty and Significance
What Is Known?
• The proepicardium is the precursor of the embryonic epicardium, the epithelium that covers the heart surface. It is a multipotent tissue capable of generating most cardiac cell types in vitro.
• The epicardium is involved in the development of coronary vessels and the cardiac interstitium, and it contributes paracrine signals crucial for myocardial growth and maturation.
• Notch is an essential signaling pathway that regulates cell fate specification and tissue patterning during heart development. Aberrant NOTCH signaling leads to human diseases affecting the heart and vascular system.
What New Information Does This Article Contribute?
• Multiple Notch ligands, receptors, and targets are differentially expressed throughout the proepicardial-epicardial-coronary transition.
• Activated Notch1 (N1ICD) and Notch2 (N2ICD) receptors and Notch target gene expression identifies active Notch signaling in epicardium.
• Systemic ablation of RBPJk, a common effector for Notch1-4 signaling, induces ectopic expression of cardiogenic genes in the proepicardium and causes abnormalities of cardiac inflow muscularization.
• Conditional Notch1 deletion in the epicardium results in abnormal differentiation of coronary artery (but not vein), including a deficient vessel wall formation, compact ventricular myocardium hypoplasia, and reduced Raldh2 expression.
• Ectopic epicardial N1ICD expression impairs myocardial development, reducing the subepicardial space and ventricular myocardium thickness.
The epicardium is essential for cardiac development and homeostasis, but the molecular mechanisms that regulate the differentiation of epicardial cells and epicardial derivatives remain unknown, and the epicardial paracrine signals contributing to myocardial growth have not been identified. We show that different Notch receptors show distinct patterns of expression during proepicardial-epicardial-coronary vessel development. The imbalance of Notch-dependent signals in the proepicardium of RBPJk mutants affects adjacent mesodermal populations and results in abnormal development of the venous pole of the heart. Later in development, Notch ablation in the epicardial cell lineage disrupts coronary vessel development, specifically affecting the differentiation of arterial (but not venous) coronary endothelium and muscularization of the vessel wall. Loss of epicardial Notch signaling also impairs compact myocardium growth. Ectopic N1ICD expression impairs epicardium development to the effect that it can no longer support normal compact myocardium growth. These findings increase our understanding of the signaling mechanisms that control epicardial development and provide insights into the role of Notch signaling in cardiovascular development that might help in the design of new therapies for heart disease.
